All public logs
Jump to navigation
Jump to search
Combined display of all available logs of wikidoc. You can narrow down the view by selecting a log type, the username (case-sensitive), or the affected page (also case-sensitive).
- 00:48, 15 February 2024 Kosar Doraghi talk contribs uploaded File:IMG 0829.jpeg
- 00:46, 15 February 2024 Kosar Doraghi talk contribs created page File:IMG 0831.jpeg
- 00:46, 15 February 2024 Kosar Doraghi talk contribs uploaded File:IMG 0831.jpeg
- 21:25, 14 February 2024 Alen Antony talk contribs created page Tirzepatide (Created page with "{{DrugProjectFormSinglePage |authorTag={{AAP}} |genericName=tirzepatide |aOrAn=a |drugClass=glucagon-like peptide-1 (GLP-1) receptor agonist |indicationType=treatment |indication=type 2 diabetes mellitus in adults in adjunct to diet and exercise. |hasBlackBoxWarning=Yes |adverseReactions=pancreatitis,hypoglycemia with concomitant use of insulin or insulin secretagogues, acute kidney injury, severe gastrointestinal disease, acute gallbladder disease, dia...")
- 18:30, 14 February 2024 Kosar Doraghi talk contribs created page Dasiglucagon (Created page with "{{DrugProjectFormSinglePage |authorTag={{KDRG}} |genericName=Dasiglucagon (ZEGALOGUE) |aOrAn=an |drugClass=anti-hypoglycemic |indicationType=treatment |indication=severe hypoglycemia in pediatric and adult patients with diabetes aged 6 years and older |hasBlackBoxWarning=Yes |adverseReactions=nausea, vomiting, headache, diarrhea, and injection site pain |blackBoxWarningTitle=Allergic reactions |blackBoxWarningBody=increase in blood pressure in Patients wi...")
- 18:17, 14 February 2024 Kosar Doraghi talk contribs created page File:IMG 0828.jpeg
- 18:17, 14 February 2024 Kosar Doraghi talk contribs uploaded File:IMG 0828.jpeg
- 18:16, 14 February 2024 Kosar Doraghi talk contribs created page File:IMG 0827.jpeg
- 18:16, 14 February 2024 Kosar Doraghi talk contribs uploaded File:IMG 0827.jpeg
- 18:13, 14 February 2024 Kosar Doraghi talk contribs created page File:IMG 0822.jpeg
- 18:13, 14 February 2024 Kosar Doraghi talk contribs uploaded File:IMG 0822.jpeg
- 18:12, 14 February 2024 Kosar Doraghi talk contribs created page File:IMG 0826.jpeg
- 18:12, 14 February 2024 Kosar Doraghi talk contribs uploaded File:IMG 0826.jpeg
- 18:07, 14 February 2024 Kosar Doraghi talk contribs created page File:IMG 0824.jpeg
- 18:07, 14 February 2024 Kosar Doraghi talk contribs uploaded File:IMG 0824.jpeg
- 18:05, 14 February 2024 Kosar Doraghi talk contribs created page File:IMG 0823.jpeg
- 18:05, 14 February 2024 Kosar Doraghi talk contribs uploaded File:IMG 0823.jpeg
- 17:59, 14 February 2024 Kosar Doraghi talk contribs created page File:IMG 0820.jpeg
- 17:59, 14 February 2024 Kosar Doraghi talk contribs uploaded File:IMG 0820.jpeg
- 17:58, 14 February 2024 Kosar Doraghi talk contribs created page File:IMG 0819.jpeg
- 17:58, 14 February 2024 Kosar Doraghi talk contribs uploaded File:IMG 0819.jpeg
- 07:05, 14 February 2024 Alen Antony talk contribs created page Spesolimab-sbzo (Created page with "{{DrugProjectFormSinglePage |authorTag={{AAP}} |genericName=Spesolimab-sbzo |drugClass=humanized monoclonal Immunoglobulin G1 antibody |indicationType=treatment |indication=generalized pustular psoriasis (GPP) flares in adults. |adverseReactions=infections, nausea, vomiting, headache, fatigue, Infusion site hematoma and bruising. |fdaLIADAdult=SPEVIGO is indicated for the treatment of generalized pustular psoriasis (GPP) flares in adults. SPEVIGO is administer...")
- 21:57, 13 February 2024 Kosar Doraghi talk contribs created page File:IMG 0813.jpeg
- 21:57, 13 February 2024 Kosar Doraghi talk contribs uploaded File:IMG 0813.jpeg
- 21:56, 13 February 2024 Kosar Doraghi talk contribs created page File:IMG 0812.jpeg
- 21:56, 13 February 2024 Kosar Doraghi talk contribs uploaded File:IMG 0812.jpeg
- 21:54, 13 February 2024 Kosar Doraghi talk contribs created page File:IMG 0817.jpeg
- 21:54, 13 February 2024 Kosar Doraghi talk contribs uploaded File:IMG 0817.jpeg
- 21:51, 13 February 2024 Kosar Doraghi talk contribs created page File:IMG 0818.jpeg
- 21:51, 13 February 2024 Kosar Doraghi talk contribs uploaded File:IMG 0818.jpeg
- 21:50, 13 February 2024 Kosar Doraghi talk contribs created page File:IMG 0816.jpeg
- 21:50, 13 February 2024 Kosar Doraghi talk contribs uploaded File:IMG 0816.jpeg
- 21:47, 13 February 2024 Kosar Doraghi talk contribs created page Vericiguat (Created page with "{{DrugProjectFormSinglePage |authorTag={{KDRG}} |genericName=VERQUVO-vericiguat |aOrAn=a |drugClass=soluble guanylate cyclase (sGC) stimulator |indicationType=treatment |indication=heart failure with reduced ejection fraction (HFrEF), reduce the risk of cardiovascular death and heart failure (HF) hospitalization following a hospitalization for heart failure or need for outpatient IV diuretics, in adults with symptomatic chronic HF and ejection fraction less t...")
- 21:43, 13 February 2024 Kosar Doraghi talk contribs created page File:IMG 0815.jpeg
- 21:43, 13 February 2024 Kosar Doraghi talk contribs uploaded File:IMG 0815.jpeg
- 03:20, 13 February 2024 Kosar Doraghi talk contribs created page File:IMG 0810.jpeg
- 03:20, 13 February 2024 Kosar Doraghi talk contribs uploaded File:IMG 0810.jpeg
- 03:18, 13 February 2024 Kosar Doraghi talk contribs created page Tapinarof (Created page with "{{DrugProjectFormSinglePage |authorTag={{KDRG}} |genericName=VTAMA- tapinarof cream |aOrAn=an |drugClass=aryl hydrocarbon receptor agonist |indicationType=treatment |indication=plaque psoriasis in adults |adverseReactions=folliculitis, nasopharyngitis, contact dermatitis, headache, and pruritus |fdaLIADAdult=Cream, 1% Each gram of VTAMA cream contains 10 mg of tapinarof in a white to off-white cream. *Apply a thin layer of VTAMA cream to affected ar...")
- 03:14, 13 February 2024 Kosar Doraghi talk contribs created page File:IMG 0809.jpeg
- 03:14, 13 February 2024 Kosar Doraghi talk contribs uploaded File:IMG 0809.jpeg
- 03:12, 13 February 2024 Kosar Doraghi talk contribs created page File:IMG 0808.jpeg
- 03:12, 13 February 2024 Kosar Doraghi talk contribs uploaded File:IMG 0808.jpeg
- 03:10, 13 February 2024 Kosar Doraghi talk contribs created page File:IMG 0807.jpeg
- 03:10, 13 February 2024 Kosar Doraghi talk contribs uploaded File:IMG 0807.jpeg
- 22:30, 12 February 2024 Alen Antony talk contribs created page Mosunetuzumab-axgb (Created page with "{{DrugProjectFormSinglePage |authorTag={{AAP}} |genericName=mosunetuzumab-axgb |aOrAn=a |drugClass=humanized monoclonal antibody |indicationType=treatment |indication=relapsing or refractory follicular lymphoma in adults after 2 or more lines of systemic therapy. |hasBlackBoxWarning=Yes |adverseReactions=cytokine release syndrome, fatigue, rash, pyrexia, and headache. |blackBoxWarningTitle=Cytokine Release Syndrome (CRS) |blackBoxWarningBody=Cytok...")
- 17:40, 12 February 2024 Kosar Doraghi talk contribs created page Spevigo- spesolimab-sbz (Created page with "{{DrugProjectFormSinglePage |authorTag={{KDRG}} |genericName=spesolimab-sbzo |aOrAn=an |drugClass=interleukin-36 receptor antagonis |indicationType=treatment |indication=generalized pustular psoriasis flares in adults |hasBlackBoxWarning=Yes |adverseReactions=asthenia and fatigue, nausea and vomiting, headache, pruritus and prurigo, infusion site hematoma and bruising, and urinary tract infection. |blackBoxWarningTitle=Warning: Hyp...")
- 22:23, 11 February 2024 Edzelco talk contribs created page Mavacamten (Created page with "{{DrugProjectFormSinglePage |authorTag={{EdzelCo}} |genericName=mavacamten |aOrAn=a |drugClass=cardiac myosin inhibitor |indicationType=treatment |indication=adults with symptomatic New York Heart Association (NYHA) class II-III obstructive hypertrophic cardiomyopathy (HCM) to improve functional capacity and symptoms |hasBlackBoxWarning=Yes |adverseReactions=dizziness (27%) and syncope (6%) |blackBoxWarningTitle=WARNING: RISK OF HEART...")
- 06:13, 11 February 2024 Alen Antony talk contribs created page Template:AAP (Created page with "Alen Antony Pathil, M.D.[mailto:alenantony657@gmail.com]")
- 19:04, 10 February 2024 Edzelco talk contribs created page Oteseconazole (Created page with "{{DrugProjectFormSinglePage |genericName=oteseconazole |aOrAn=an |drugClass=azole antifungal |indicationType=prevention |indication=recurrent vulvovaginal candidiasis (RVVC) in females with a history of RVVC who are NOT of reproductive potential |adverseReactions=headache and nausea |fdaLIADAdult=VIVJOA Capsules: 150 mg of oteseconazole in lavender hard gelatin capsules imprinted with OTE 150 in black ink. Fluconazole is not supplied in the carton. |co...")
- 19:02, 10 February 2024 Edzelco talk contribs created page File:VIVJOA label3.png